News
2 minute read

MBHB Partner Kevin Noonan Quoted in BioPharma Reporter Article Entitled, "Pfizer plans for October Remicade biosimilar launch, boosted by IP ruling"

Kevin E. Noonan, Ph.D.August 19, 2016

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin Noonan is quoted in an August 19, 2016 edition of BioPharma-Reporter.com in an article entitled, “Pfizer plans for October Remicade biosimilar launch, boosted by IP ruling.” An invalidated Remicade patent has paved the way for Pfizer to launch Inflectra in October, but legal battles with J&J are far from over says an IP lawyer. View the article